<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
<title>Insider Trading Headlines for Thursday June 21st 2018 | Insider Insights</title>
<link href="http://www.insiderinsights.com/insider-news-headlines/2018-06-21" ></link>
<id>urn:uuid:d1b49804-c45d-dc98-cc66-b74dd3176566</id>
<updated>2026-09-19T10:31:41-04:00</updated>
<author>Jonathan Moreland</author>
<subtitle>Profit from legal insider trading. InsiderInsights.com provides free insider trading data tools and resources, and professional grade subscription based real time Form 4 data, analysis and services</subtitle>
<entry>
<title>ABUS: HASTINGS DAVID C (CFO) Filed a Form 3, Becoming a Registered Insider at ARBUTUS BIOPHARMA CORP With Initial  Holdings of 0</title>
<link href="http://www.insiderinsights.com/company/abus/arbutus-biopharma-corp/id-3608293" ></link>
<id>urn:uuid:edaff39e-5c72-4ee3-42b0-2062391f62be</id>
<updated>2018-06-21T17:50:28-04:00</updated>
<summary type="html" ><![CDATA[ARBUTUS BIOPHARMA CORP (ABUS). Recent Price: $5.01. Mkt Cap:992.5mm. 10D Vol: 4.1mm]]></summary>
</entry>
</feed>